Founded in 1963, Biotronik is a multinational biomedical technology company that designs, manufactures, and markets medical devices for the treatment of cardiac arrhythmia, vascular diseases, heart failure, and coronary and peripheral artery diseases. It is headquartered in Berlin, Germany and has manufacturing sites in Germany, United States, and Switzerland.
In its early years, the company manufactured implantable pacemakers. Later, it ventured in to developing a comprehensive spectrum of vascular intervention and electrophysiology products. Currently, Biotronik’s product portfolio caters to three main segments – cardio rhythm management, vascular intervention, and electrophysiology.
Biotronik has employees in over 50 countries, with research and development centers in North America, Europe, and Singapore. This report takes a closer look at the patent assets held by Biotronik. It includes a portfolio taxonomy and provides insights into various aspects of the overall portfolio.
